Patent ID: 7959566

Claim:
A method of treating a male patient, suffering from erythema nodosum leprosum, with thalidomide, by permitting prescriptions for thalidomide to be filled by a pharmacy only after the pharmacy has retrieved a prescription approval code for the prescription, comprising the following steps: (a) via a non-transitory computer readable storage medium, registering a prescriber and the pharmacy with a distributor of thalidomide; (b) determining whether the patient is able to understand and carry out instructions; (c) upon determination that the patient is able to carry out the instructions, providing verbal and written warnings of the hazard of taking thalidomide and exposing fetus to the drug; (d) further providing verbal and written warnings of the risk of possible contraception failure and of the need to use barrier contraception when having sexual intercourse with women of child bearing potential; (e) obtaining acknowledgement of said warnings from the patient; (f) providing the prescription for thalidomide to the patient from the prescriber; (g) via a non-transitory computer readable storage medium, registering the patient with the distributor; (h) upon obtaining the acknowledgement and registrations, generating the prescription approval code, and via a non-transitory computer readable storage medium, retrieving the prescription approval code by the pharmacy before the prescription is filled; and (i) upon retrieving the prescription approval code, administering thalidomide to the patient.